Optimize, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Privately held developer of eyeglass-mounted imaging systems will ramp up sales and marketing initiatives for its FDA-cleared OptiVu HDVD minimally invasive surgical display system following the completion of a $14 mil. round of financing. The system will be introduced at the Oct. 22-27 Annual Clinical Congress of the American College of Surgeons in Chicago. The device consists of a wireless headset, a videoscopic camera, a base station to receive signals from the camera and convert them for infrared transmission, and an IR transceiver to send and receive the IR signal to and from the headset. The headset "produces an apparent, full-color endoscopic image directly in the line of sight of surgeons," the firm explains. "We exceeded our targeted investment, reflecting the excitement about our technology and product," said CEO Jim Pfeiffer. Invesco Global Health Sciences Fund led new investors while contributing previous investors included St. Paul Venture Capital, Patricof & Co., and Crescendo Ventures